Medtronic's MiniMed 670G - the closest thing yet to an artificial pancreas - has been launched in the US. The so-called 'hybrid closed-loop' system comprises a blood glucose sensor ...

A month has gone by since the last earnings report for Medtronic (MDT). Shares have added about 0.7% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up ...

That includes the MiniMed 780G automated insulin delivery (AID) system, cleared by the U.S. Food and Drug Administration (FDA) in 2023. This helped the Diabetes segment's organic sales increase by ...

As chronic illnesses rise and technology leaps forward, the demand for cutting-edge medical devices intensifies. Medtronic ...

The recent boost is partly due to Medtronic's newest insulin pump, the MiniMed 780G, which earned clearance in the U.S. in April 2023. One of this device's biggest perks is that it features an ...

U.S. revenues grew in the mid-teens on the continued adoption of the MiniMed 780G automated insulin delivery system. International revenues grew by low double digits on increasing CGM attachment ...

In April, Medtronic obtained FDA approval for another new product, Inceptiv, a spinal cord stimulator for treating chronic pain. The device can automatically adjust the therapy — a unique feature — to ...

Selbyville, Delaware, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Sensor Patch market is estimated to reach USD 60 billion by 2032, as ...

Medtronic faced challenges, including poor focus, lack of innovation, and COVID-19 impact, leading to share price stagnation since 2018. Despite recent improvements in performance, Medtronic ...

Moreover, I've completed a comparative analysis of the system relative to Medtronic's (MDT) MiniMed system and Tandem Diabetes (TNDM) tX2 with the control-IQ technology (Figure 3). The question is ...

Disclosure: R.J.H. has received research support from GlaxoSmithKline, Minimed-Medtronic, Novartis, and Novo Nordisk and has served on advisory boards for Amylin, Bristol-Myers Squibb, Merck ...

The headline numbers from Medtronic highlight a solid start to its fiscal 2025. For the company's first quarter, adjusted ...